Coeptis Therapeutics Holdings, Inc.
Revenue breakdown: Advertising Campaigns (91.7%), Webinar Services (8.3%).
8-K
Coeptis Therapeutics Holdings, Inc. implemented an option repricing/exchange program for officers and directors, converting certain out-of-the-money options to restricted stock and accelerating the vesting of all options. The company also regained compliance with Nasdaq listing rules after previously failing to hold a required annual meeting.